Indian pharma industry forecast to grow 11%-12% this year

8 July 2019

A moderation in pricing pressure for the US market, new launches and market share gains for existing products along with consolidation benefits are set to drive growth for India’s pharmaceutical industry in fiscal year 2020, reports The Pharma Letter’s local correspondent.

Rating agency ICRA has said India’s pharmaceutical industry is set to grow by 11%-13% in the current fiscal.

Growth, however, would be constrained by regulatory interventions such as price controls, compulsory genericization, and US Food and Drug Administration oversight for manufacturing deficiencies, the rating agency said.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK